BioMarin Pharmaceutical (BMRN) News Today $65.66 +0.66 (+1.02%) (As of 12/20/2024 05:15 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Stifel Financial Corp Has $2.15 Million Stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Stifel Financial Corp lowered its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 30.6% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 30,537 shares of the biotechnology compDecember 20 at 3:38 AM | marketbeat.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Given Average Rating of "Moderate Buy" by AnalystsShares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Get Free Report) have received an average recommendation of "Moderate Buy" from the twenty-three ratings firms that are currently covering the stock, Marketbeat reports. Seven equities research analysts have rated the stock with a hold rating, fDecember 20 at 3:01 AM | marketbeat.comNational Bank of Canada FI Decreases Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)National Bank of Canada FI trimmed its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 93.6% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 919 shares of the biotechnology company's stock after selling 13December 18 at 3:45 AM | marketbeat.comTidal Investments LLC Increases Stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Tidal Investments LLC boosted its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 150.4% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 30,467 shares of the biotechnology company'sDecember 17, 2024 | marketbeat.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Acquired by Geode Capital Management LLCGeode Capital Management LLC boosted its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 1.9% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,260,050 shares of the biotechnology company's stDecember 15, 2024 | marketbeat.comVirtu Financial LLC Acquires New Stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Virtu Financial LLC bought a new position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 11,504 shares of the biotechnology company's stock, valued atDecember 14, 2024 | marketbeat.comTeachers Retirement System of The State of Kentucky Has $4.22 Million Stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Teachers Retirement System of The State of Kentucky reduced its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 69.1% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 60,040 shares of the biotDecember 14, 2024 | marketbeat.comAre BioMarin Pharmaceutical Inc.'s (NASDAQ:BMRN) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?December 11, 2024 | uk.finance.yahoo.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Position Increased by Neo Ivy Capital ManagementNeo Ivy Capital Management raised its holdings in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 2,225.2% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 21,020 shares of the biotechnology company's stock afteDecember 11, 2024 | marketbeat.comY Intercept Hong Kong Ltd Buys Shares of 28,230 BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Y Intercept Hong Kong Ltd purchased a new stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 28,230 shares of the biotechnology company's stock, vDecember 11, 2024 | marketbeat.comFmr LLC Grows Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Fmr LLC lifted its holdings in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 21.7% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 206,538 shares of the biotechnology company's stock after pDecember 11, 2024 | marketbeat.comNomura Asset Management Co. Ltd. Has $34.13 Million Stock Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Nomura Asset Management Co. Ltd. lifted its holdings in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 29.5% in the third quarter, according to its most recent filing with the SEC. The firm owned 485,609 shares of the biotechnology company's stock after acquiring an additionaDecember 10, 2024 | marketbeat.comTwo Sigma Advisers LP Decreases Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Two Sigma Advisers LP cut its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 21.8% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 181,314 shares of the biotechnology company's stock after sDecember 10, 2024 | marketbeat.comWorldquant Millennium Advisors LLC Invests $4.47 Million in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Worldquant Millennium Advisors LLC purchased a new position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 63,572 shares of the biotechDecember 8, 2024 | marketbeat.comCentiva Capital LP Makes New Investment in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Centiva Capital LP acquired a new stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 7,511 shares of the biotechnology company's stock, valueDecember 8, 2024 | marketbeat.comJacobs Levy Equity Management Inc. Invests $3.66 Million in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Jacobs Levy Equity Management Inc. bought a new stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 52,071 shares of the biotechnology company's stoDecember 7, 2024 | marketbeat.comBioMarin Pharmaceutical: Undervalued Opportunity with Potential for Margin Expansion and Strategic GrowthDecember 5, 2024 | markets.businessinsider.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Sold by Motley Fool Wealth Management LLCMotley Fool Wealth Management LLC trimmed its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 4.7% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 424,597 shares of the bDecember 4, 2024 | marketbeat.comHolocene Advisors LP Trims Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Holocene Advisors LP reduced its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 21.0% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 563,476 shares of the biotechnology company's stock after selling 149,628 shares during the period. HolDecember 3, 2024 | marketbeat.comEdgestream Partners L.P. Acquires Shares of 28,562 BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Edgestream Partners L.P. acquired a new stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 28,562 sharesDecember 3, 2024 | marketbeat.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Stock Position Lessened by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLCUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC decreased its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 13.1% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange CommissionDecember 3, 2024 | marketbeat.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Sold by The Manufacturers Life Insurance CompanyThe Manufacturers Life Insurance Company lowered its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 11.5% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor ownDecember 3, 2024 | marketbeat.comRockefeller Capital Management L.P. Raises Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Rockefeller Capital Management L.P. grew its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 16.5% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 266,633 shares of the biotechnology cDecember 2, 2024 | marketbeat.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Sold by BNP Paribas Financial MarketsBNP Paribas Financial Markets trimmed its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 77.9% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 150,364 shares of the biotechnolDecember 2, 2024 | marketbeat.comErste Asset Management GmbH Invests $48.53 Million in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Erste Asset Management GmbH acquired a new stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 689,935 shares of the biotechnology company's stock, valDecember 1, 2024 | marketbeat.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Stock Holdings Increased by Bellevue Group AGBellevue Group AG grew its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 533.7% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 330,976 shares of the biotechnology compDecember 1, 2024 | marketbeat.comPDT Partners LLC Buys Shares of 33,028 BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)PDT Partners LLC purchased a new position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 33,028 shares of the biotechnology coDecember 1, 2024 | marketbeat.comVestal Point Capital LP Buys New Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Vestal Point Capital LP purchased a new position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 400,000 shares of the biotechNovember 29, 2024 | marketbeat.comBridgewater Associates LP Increases Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Bridgewater Associates LP increased its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 306.8% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 142,314 shares of the biotechnology company's stockNovember 29, 2024 | marketbeat.comFORA Capital LLC Acquires 16,926 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)FORA Capital LLC increased its holdings in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 199.8% during the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 25,399 shares of the biotechnology company's stockNovember 28, 2024 | marketbeat.comRBC Capital Keeps Their Hold Rating on BioMarin Pharmaceutical (BMRN)November 28, 2024 | markets.businessinsider.com14,376 Shares in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Acquired by Dynamic Technology Lab Private LtdDynamic Technology Lab Private Ltd bought a new stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 14,376 shares of the biotechnology company's stock, valued aNovember 28, 2024 | marketbeat.comWhy Is BioMarin Pharmaceutical Inc. (BMRN) Among the Worst Performing Healthcare Stocks in 2024?November 27, 2024 | insidermonkey.comCharles Schwab Investment Management Inc. Has $98.52 Million Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Charles Schwab Investment Management Inc. boosted its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 4.1% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,401,628 shaNovember 27, 2024 | marketbeat.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Purchased by Swedbank ABSwedbank AB boosted its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 34.7% during the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 388,529 shares of the biotechnology company's stock after buying an additional 100,000 shaNovember 26, 2024 | marketbeat.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Receives Average Rating of "Moderate Buy" from AnalystsBioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Get Free Report) has earned a consensus rating of "Moderate Buy" from the twenty-three analysts that are currently covering the firm, Marketbeat Ratings reports. Seven research analysts have rated the stock with a hold recommendation, fifteen have issuedNovember 25, 2024 | marketbeat.comKing Luther Capital Management Corp Makes New Investment in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)King Luther Capital Management Corp acquired a new stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 28,840 shares of the biotechnology company's stock,November 23, 2024 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Invests $8.17 Million in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Connor Clark & Lunn Investment Management Ltd. acquired a new stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund acquired 116,257 shares of the biotechnology company's stock, valued at aNovember 23, 2024 | marketbeat.comCan BioMarin Stock Live Up to Wall Street's High Expectations?November 22, 2024 | msn.comWhat is Zacks Research's Forecast for BMRN FY2024 Earnings?BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) - Stock analysts at Zacks Research raised their FY2024 EPS estimates for BioMarin Pharmaceutical in a research report issued to clients and investors on Tuesday, November 19th. Zacks Research analyst S. Ganoria now expects that the biotechnNovember 22, 2024 | marketbeat.comCan BioMarin Stock Live Up to Wall Street’s High Expectations?BioMarin has greatly improved the fundamentals of its business, but continues losing value. Is the tide ready to turn, or is more of the same on the horizon?November 22, 2024 | marketbeat.comJefferies Sticks to Their Buy Rating for BioMarin Pharmaceutical (BMRN)November 21, 2024 | markets.businessinsider.comBiomarin: Challanges Mount, But Sale Rumours Make For A Risky "Buy" CallNovember 21, 2024 | seekingalpha.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Acquired by Primecap Management Co. CAPrimecap Management Co. CA lifted its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 0.4% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 18,867,435 shares of the biotechnology company's stock afNovember 21, 2024 | marketbeat.comZacks Research Issues Positive Estimate for BMRN EarningsBioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) - Investment analysts at Zacks Research lifted their Q1 2025 earnings estimates for BioMarin Pharmaceutical in a report released on Tuesday, November 19th. Zacks Research analyst S. Ganoria now expects that the biotechnology company will poNovember 21, 2024 | marketbeat.comBioMarin Pharmaceutical Inc. (BMRN): Among the Best Genomics Stocks to Buy Right NowNovember 20, 2024 | msn.comEULAV Asset Management Buys 15,000 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)EULAV Asset Management lifted its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 12.9% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 131,000 shares of the biotechnolNovember 20, 2024 | marketbeat.comHowe & Rusling Inc. Grows Stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Howe & Rusling Inc. grew its holdings in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 101.2% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 49,652 shares of the biotechnology company's sNovember 20, 2024 | marketbeat.comCautious Optimism: Hold Rating on BioMarin Amid Promising Trial Data and Sector RisksNovember 18, 2024 | markets.businessinsider.comBioMarin : Real-World Evidence Supports Safety, Efficacy Of VOXZOGO In Children With AchondroplasiaNovember 18, 2024 | markets.businessinsider.com Get BioMarin Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for BMRN and its competitors with MarketBeat's FREE daily newsletter. Email Address Could This Tiny Device Help You Make an Extra $30k a Year? (Ad)I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED. Click here to see the details because I believe a lot of people will get rich. BMRN Media Mentions By Week BMRN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BMRN News Sentiment▼1.380.60▲Average Medical News Sentiment BMRN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BMRN Articles This Week▼59▲BMRN Articles Average Week Get BioMarin Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for BMRN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ALNY News Today BIIB News Today UTHR News Today NBIX News Today INCY News Today EXAS News Today EXEL News Today RGEN News Today MDGL News Today HALO News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BMRN) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioMarin Pharmaceutical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioMarin Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BMRN Stock Alerts